How low an effect of a preventive measure against diarrhoea are travellers willing to pay for?: A survey of Norwegian travellers.
Travel Med Infect Dis
; 14(6): 621-624, 2016.
Article
em En
| MEDLINE
| ID: mdl-27777090
ABSTRACT
BACKGROUND:
Traveller's diarrhoea (TD) is the most common infectious problem for travellers, and we lack effective ways of preventing it, apart from antibiotic prophylaxis. This study aims to quantify the risk reduction of a hypothetic TD vaccine Norwegian travellers are willing to pay for.METHODS:
1204 clients at Reiseklinikken responded to a questionnaire asking what level of effectiveness would be required of a hypothetical vaccine against TD costing US$65.RESULTS:
18.7% of the respondents would buy the vaccine even if it was only 20% effective. Among respondents older than 50 years, the proportion was 28.8%.CONCLUSIONS:
Our findings should encourage the development of vaccines and other preventive measures against travellers' diarrhoea.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Viagem
/
Vacinas
/
Diarreia
Tipo de estudo:
Etiology_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article